Bullish Case: Calls outtraded puts 59% and bullish risk exceeds bearish by 14% across tenors; top prints cluster in 145–150 calls (Feb-27 150C leads volume). The curve sits in contango with Nov-21 IV peaking at 66.4% — event pricing, not distress. August patent wins in Taiwan/China defend the CMP-slurry moat, and spot holds above both Helium and market PDF modes (~130). If AI-driven fab capex holds through late-October earnings, a grind toward 150–160 into January is the path of least resistance.

Bearish Case: Both Helium and market risk-neutral densities mode near 125–135, below spot $138.74, and Helium's curve carries a fat left tail (0.026–0.036 density at $90–95). Price action is mean-reverting after a +69% year; volume sits at the 5th percentile, weakening the call-lead signal. The AI forecast's -0.1 realized correlation neutralizes its +5.01% print — my prior bearish tilts also missed. Deep-OTM put IVs (95–110 strikes: 76–107%) show standing crash hedges; a late-October guidance miss reopens $120 quickly.

Potential Outcomes:

1. 35%: $130–148 range through late-Oct earnings; falsified if Sep-18 140C IV (>56%) collapses while spot <$135.
2. 20%: Breakout $150–165 by Jan-16 expiry on capex beat; falsified if Nov-21 150C IV slips under 60%.
3. 10%: Squeeze >$165.
4. 22%: Drift $120–130 on Sept FOMC/soft guide.
5. 13%: Shock <$115 (persistent SPY downside skew). Nov-21's 66.4% IV peak prices the earnings event; contango historically favors defined-risk short-premium structures over naked longs.

September 05, 2026